UC College of Engineering and Applied Science professor and founder of Siloam Biosciences Inc., Chong Ahn, PhD, has been advised that Siloam Biosciences, Inc. has been nominated for a 2013 Business Courier Innovation award.
The Innovation Awards celebrate innovative people and companies “that show how new ideas can be developed into fuel for the Tri-State’s economic engine.” The award is being presented by the Cincinnati USA Regional Chamber and Community Partner, the Business Courier and CincyTech.
In 2004 Ahn launched Siloam Biosciences Inc. to develop products using microfluidic polymer lab-on-a-chip that helped point-of-care testing (POCT) based clinical diagnostics. Subsequently, Siloam Biosciences, Inc. developed what their website states is “the first ever microfluidic immunoassay platform designed to provide the dramatic benefits of microfluidics in a product that is as easy to use as an innovative POCT platform.”
Ahn, who is M. P. Kartalia Chair Professor of Electrical Engineering and the Director of the Microsystems and BioMEMS Laboratory at UC, holds six U.S. patents, filed ten patents, and has published over ~300 journal and peer-reviewed conference papers related to microfluidics and smart lab-on-a-chip (LOC) technology. This state-of-the-art technology has opened a new door for point-of-care (POCT) in vitro diagnostics (IVD) to quickly analyze a person’s health condition and status.
These faster diagnoses and more immediate test results are the desires of many patients and physicians. “Polymer smart LOC with microfluidics is one of the most innovative platforms for a better analysis of biochemical molecules,” said Ahn. “The microfluidics and lab-on-a-chips can be applied to in vitro diagnostics (IVD), ELISA, and point-of-care testing (POCT) clinical diagnostics and a couple of lab-on-a-chip and microfluidic platforms developed in this lab have been transferred for commercial products.”